SC 13D

Company

Hepion Pharmaceuticals, Inc.

Filed

October 7, 2013

Accession Number

0001104659-13-074385

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →